Original Article
Fluticasone in mild to moderate atopic dermatitis relapse: A randomized controlled trial
E. Rubio-Gomisa,b,
, I. Martinez-Mirc, F.J. Morales-Olivasb, A. Martorell-Aragonesd, V. Palop-Larreae, A. Bernalte-Seséf, J.C. Cerda-Mird, P. Polo-Martíng, I. Febrerh, L. Aranda-Graui, I. Llosa-Cortesj, Mª.J. Tejedor-Sanzk, J.C. Julia-Benitol, T. Alvarez-de-Laviada-Mulerog, Mª.V. Planelles-Cantarinom, E. Apolinar-Valienten, M. Loriente-Turo, A.M. Abella-Bazataquii, I. Alvarez-Gonzalezp, C. Morales-Carpiq..., Mª.E. Burches-Greusr, A.B. Ferrer-Bautistam, R. Felix-Toledod, D. Marmaneu-Laguiao, V.E. Garcia-Martinezo, Mª.A. Beltran-Marquesn, B. Rodriguez-GraciasVer más
Corresponding author
a Unidad de Farmacología Clínica, Consorcio Hospital General Universitario de Valencia CHGUV, Valencia, Spain
b Departamento Farmacología, Universitat de Valéncia, Valencia, Spain
c Dirección Gerencia-Fundación HGU, CHGUV, Valencia, Spain
d Unidad de Alergía Pediátrica, CHGUV, Valencia, Spain
e Subdirección Médica Asistencial, Departamento de Salud La Ribera, Alzira, Valencia, Spain
f Servicio de Farmacia, CHGUV, Valencia, Spain
g Centro de Salud (CS) Barrio de la Luz, Xirivella, Valencia, Spain
h Servicio Dermatología, CHGUV, Valencia, Spain
i Centro de Atención Primaria de Pobla de Vallbona, Valencia, Spain
j CS Monserrat, Valencia, Spain
k CS Torrente II, Valencia, Spain
l CS Alzira, Valencia, Spain
m CS Paiporta, Valencia, Spain
n CS Torrente I, Valencia, Spain
o CS Alacuas, Valencia, Spain
p CS Burjasot II, Valencia, Spain
q CS Picasent, Valencia, Spain
r CS Xirivella, Valencia, Spain
s CS Auxiliar El Vedat de Torrent, Valencia, Spain
Ver másRead
4930
Timeswas read the article
1051
Total PDF
3879
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 60 | 29 | 89 |
| 2025 11 | 216 | 114 | 330 |
| 2025 10 | 146 | 3 | 149 |
| 2025 9 | 149 | 13 | 162 |
| 2025 8 | 161 | 20 | 181 |
| 2025 7 | 122 | 7 | 129 |
| 2025 6 | 82 | 6 | 88 |
| 2025 5 | 68 | 7 | 75 |
| 2025 4 | 90 | 18 | 108 |
| 2025 3 | 69 | 5 | 74 |
| 2025 2 | 51 | 14 | 65 |
| 2025 1 | 55 | 12 | 67 |
| 2024 12 | 52 | 1 | 53 |
| 2024 11 | 38 | 8 | 46 |
| 2024 10 | 28 | 6 | 34 |
| 2024 9 | 40 | 7 | 47 |
| 2024 8 | 38 | 7 | 45 |
| 2024 7 | 32 | 13 | 45 |
| 2024 6 | 35 | 3 | 38 |
| 2024 5 | 35 | 6 | 41 |
| 2024 4 | 63 | 24 | 87 |
| 2024 3 | 145 | 5 | 150 |
| 2024 2 | 62 | 6 | 68 |
| 2024 1 | 58 | 9 | 67 |
| 2023 12 | 57 | 23 | 80 |
| 2023 11 | 56 | 19 | 75 |
| 2023 10 | 66 | 15 | 81 |
| 2023 9 | 56 | 7 | 63 |
| 2023 8 | 53 | 5 | 58 |
| 2023 7 | 59 | 10 | 69 |
| 2023 6 | 65 | 108 | 173 |
| 2023 5 | 79 | 15 | 94 |
| 2023 4 | 66 | 7 | 73 |
| 2023 3 | 66 | 7 | 73 |
| 2023 2 | 54 | 14 | 68 |
| 2023 1 | 60 | 9 | 69 |
| 2022 12 | 45 | 15 | 60 |
| 2022 11 | 50 | 17 | 67 |
| 2022 10 | 53 | 14 | 67 |
| 2022 9 | 36 | 18 | 54 |
| 2022 8 | 57 | 41 | 98 |
| 2022 7 | 61 | 24 | 85 |
| 2022 6 | 46 | 15 | 61 |
| 2022 5 | 34 | 21 | 55 |
| 2022 4 | 54 | 25 | 79 |
| 2022 3 | 81 | 22 | 103 |
| 2022 2 | 79 | 17 | 96 |
| 2022 1 | 73 | 15 | 88 |
| 2021 12 | 52 | 19 | 71 |
| 2021 11 | 65 | 18 | 83 |
| 2021 10 | 63 | 21 | 84 |
| 2021 9 | 38 | 13 | 51 |
| 2021 8 | 64 | 19 | 83 |
| 2021 7 | 36 | 27 | 63 |
| 2021 6 | 37 | 36 | 73 |
| 2021 5 | 47 | 9 | 56 |
| 2021 4 | 62 | 21 | 83 |
| 2021 3 | 40 | 12 | 52 |
| 2021 2 | 23 | 12 | 35 |
| 2021 1 | 38 | 13 | 51 |
| 2020 12 | 6 | 2 | 8 |
| 2020 7 | 0 | 1 | 1 |
| 2019 5 | 2 | 0 | 2 |
| 2019 2 | 1 | 0 | 1 |
| 2018 7 | 3 | 0 | 3 |
| 2018 6 | 1 | 0 | 1 |
| 2018 2 | 0 | 2 | 2 |
Show all
